GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » FCF Margin %

Yunkang Group (HKSE:02325) FCF Margin % : 36.12% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Yunkang Group's Free Cash Flow for the six months ended in Dec. 2023 was HK$163.8 Mil. Yunkang Group's Revenue for the six months ended in Dec. 2023 was HK$453.5 Mil. Therefore, Yunkang Group's FCF Margin % for the quarter that ended in Dec. 2023 was 36.12%.

As of today, Yunkang Group's current FCF Yield % is 4.48%.

The historical rank and industry rank for Yunkang Group's FCF Margin % or its related term are showing as below:

HKSE:02325' s FCF Margin % Range Over the Past 10 Years
Min: -11.53   Med: -5.35   Max: 30.47
Current: 30.47


During the past 6 years, the highest FCF Margin % of Yunkang Group was 30.47%. The lowest was -11.53%. And the median was -5.35%.

HKSE:02325's FCF Margin % is ranked better than
97.26% of 219 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.13 vs HKSE:02325: 30.47


Yunkang Group FCF Margin % Historical Data

The historical data trend for Yunkang Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunkang Group FCF Margin % Chart

Yunkang Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial -11.53 -5.90 8.46 -4.80 30.47

Yunkang Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only 21.19 -24.44 6.59 25.55 36.12

Competitive Comparison of Yunkang Group's FCF Margin %

For the Diagnostics & Research subindustry, Yunkang Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yunkang Group's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Yunkang Group's FCF Margin % falls into.



Yunkang Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Yunkang Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=297.102/975.104
=30.47 %

Yunkang Group's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=163.816/453.519
=36.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yunkang Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of Yunkang Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Yunkang Group (HKSE:02325) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Lizhishan Road, Science City, Huangpu District, Guangzhou, CHN
Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.
Executives
Huizekx Limited 2201 Interest of corporation controlled by you
Yk Development Limited 2101 Beneficial owner
Zhang Yong 2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd 2201 Interest of corporation controlled by you
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si 2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Jin Jun Ying Limited 2201 Interest of corporation controlled by you
Mouduans Limited 2201 Interest of corporation controlled by you
Source Capital Rw Limited 2201 Interest of corporation controlled by you
Tongfuzc Limited 2201 Interest of corporation controlled by you
Wjjr Investment Limited 2201 Interest of corporation controlled by you

Yunkang Group (HKSE:02325) Headlines

No Headlines